WCG Talks Trials
WCG
Categorias: Salud
Añadir a Mi Lista
Escuchar el último episodio:
In the most recent episode of WCG Talks Trials, we are joined by three industry experts, Amy Thue and Shelby Ward from WCG, and Russell Lampman from Merck to discuss the topic of optimizing vendor support, and ultimately the success, of clinical trials.
Listen in as we dive into feedback and perspectives from both the sponsor and vendor side of the table—for valuable take-aways and insights into how vendor support is best aligned across all stakeholders.
Episodios anteriores
-
70 - Creating Partnerships: Aligning Vendor Support for Success in Clinical ResearchWed, 06 Mar 2024
-
69 - WCG's IRB Policy Change: Harmonizing Consent (Part 2)Tue, 27 Feb 2024
-
68 - WCG's IRB Policy Change: Harmonizing Consent (Part 1)Tue, 27 Feb 2024
-
67 - The Ethical and Safety Considerations of Accelerating Oncology TrialsTue, 16 Jan 2024
-
66 - Embarking on a Research Revolution – A Conversation with Florence HealthcareMon, 18 Dec 2023
-
65 - The CRA’s Evolving Role in a Postpandemic IndustryThu, 14 Dec 2023
-
64 - MAGI@home: Practical Intelligence, Real-life Examples, Actionable InformationMon, 04 Dec 2023
-
63 - Diversity & Inclusion with Technology in Decentralized TrialsWed, 22 Nov 2023
-
62 - Amplifying Patient Voices to Advance Clinical Research: The Importance of Patient AdvocacyMon, 13 Nov 2023
-
61 - The Importance of Diversity, Equity, Inclusion, and Intersectionality in Clinical ResearchFri, 27 Oct 2023
-
60 - Delve into the World of Psychedelic Research and Ethical InquiryTue, 26 Sep 2023
-
59 - A 360-degree View on Motivators and Deterrents to Clinical Trial ParticipationMon, 11 Sep 2023
-
58 - Breaking Down Enrollment Barriers: How DE&I, Technology, and Protocol Design Impact Enrollment SuccessWed, 16 Aug 2023
-
57 - Unlocking Site Potential: Reducing Site Burden and Enhancing Clinical Trial EfficiencySun, 16 Jul 2023
-
55 - Connecting Patients to Trials: Bernadette Siddiqi of The Michael J. Fox Foundation for Parkinson’s ResearchWed, 16 Dec 2020
-
53 - On the Future of Movement Disorder Trials: Part 4 of WCG’s Transforming CNS Trials SeriesWed, 21 Oct 2020
-
52 - Prostate Cancer Survivor Bryce Olson’s Message: “Sequence Me!”Thu, 08 Oct 2020
-
51 - On the Future of Depression Trials: Part 3 of WCG’s Transforming CNS Trials SeriesWed, 30 Sep 2020
-
50 - LaTasha H. Lee, PhD, MPH: Advocating for Health Equity, Advancing Sickle Cell Disease ResearchTue, 29 Sep 2020
-
49 - Jeffrey Borghoff: Finding Joy and Purpose after an Early-Onset Alzheimer’s DiagnosisThu, 24 Sep 2020
-
48 - On the Future of Schizophrenia Trials: Part 2 of WCG’s Transforming CNS Trials SeriesMon, 21 Sep 2020
-
47 - Lisa Deck: Young Stroke Survivor Transforms Life-Altering Challenge into Purpose-Driven Advocacy for OthersWed, 16 Sep 2020
-
46 - The Case for Centralized Monitoring: Optimizing Data Quality and Risk Management with Linda Sullivan and Steve YoungMon, 31 Aug 2020
-
45 - Michael Poku, MD, MBA: Improving Minority Representation in Clinical TrialsFri, 28 Aug 2020
-
44 - Dana Deighton: Esophageal Cancer Patient and Persistent Activist For Her Own SurvivalThu, 27 Aug 2020
-
43 - Striving for Reliability: Optimizing Patient Report Data through World-Class Design Management with Linda Sullivan, Nat Katz, and Art MoralesThu, 27 Aug 2020
-
42 - The Upside of Centralized Monitoring During a Pandemic: Linda Sullivan, Duncan Hall, and Rachel Oakley on Optimizing Clinical Trials through Innovative RBQM TechnologyWed, 19 Aug 2020
-
41 - Get Rid of Those Silos: Linda Sullivan, Artem Andrianov, and Johann Proeve on How To Optimize Clinical Trials through RBQMMon, 17 Aug 2020
-
40 - Gregory L. Hall, MD: Writing the Book on Health Disparities in African AmericansThu, 30 Jul 2020
-
39 - Turning Insights Into Action: Linda Sullivan and Ken Getz on How Metrics and Benchmarking Provide a Path To Optimizing Clinical TrialsWed, 29 Jul 2020
-
38 - Peter A. DiBiaso, MHA: Taking on the Ironman, Mount Kilimanjaro and Parkinson’s disease: a clinical trials patient recruitment expert speaks about his own life as a patientWed, 29 Jul 2020
-
37 - Lisa Carlton, PhD: Fighting Rare Diseases as a Mother, Patient Advocate and Regulatory Affairs ProfessionalWed, 29 Jul 2020
-
36 - Now Is the Time: Making Your Clinical Trial More ResilientFri, 24 Jul 2020
-
35 - Hong Liu, PhD, Making Chicago a Healthier City for Asian AmericansTue, 21 Jul 2020
-
34 - Roslyn Daniels, Black Health Matters Founder and President, on Health Disparities and Exciting Communities About HealthWed, 08 Jul 2020
-
33 - Dorelia Rivera: Health Disparities, a Career in Advocacy, and Saving Her Daughter’s LifeFri, 12 Jun 2020
-
32 - Christopher Gantz, Building Trust and minority enrollment in clinical trials at Thomas Jefferson Hospital in PhiladelphiaFri, 12 Jun 2020
-
31 - Communicating the Value of Clinical Trials to Underserved Minority CommunitiesMon, 08 Jun 2020
-
30 - People, Process and Technology: The Right Combination for Successful Expert CommitteesWed, 03 Jun 2020
-
29 - Bringing Clinical Trials Closer to Home: Smaller, Local Sites Build Trust & Provide Access to Local CommunitiesFri, 15 May 2020
-
28 - Raise Your Voices: Social Network Provides Safe Place for Patients to Share Stories and Influence ResearchWed, 06 May 2020
-
27 - Frank Sasinowski, MS, MPH, JD Hymen Phelps & McNamara: Rare Disease Regulatory Transformation: 1983 AIDS Crisis to PresentTue, 28 Apr 2020
-
26 - Brian Loew, The INSPIRE social network platform provides a safe place for patients to meet, learn, and influence researchTue, 28 Apr 2020
-
25 - Thomas Farrington: Cancer Survivor’s Prostate Health Network gets African American Communities Talking About Prostate CancerTue, 21 Apr 2020
-
24 - We Should Not Be Surprised: COVID-19 Disparities Lay Bare What’s Been There All AlongFri, 17 Apr 2020
-
23 - COVID-19 Doesn’t Play Fair: What We Need to Understand About Racial DisparitiesWed, 15 Apr 2020
-
22 - Dr. David Fajgenbaum, MD, Castleman’s Disease Survivor, Facing COVID-19 with Research, Action, and HopeWed, 01 Apr 2020
-
21 - Turning Passion Into a Career: Insights from a Physician and Industry Medical Director of AbbVie Pharmaceuticals, Charlotte Owens, MD, FACOGMon, 24 Feb 2020
-
20 - Biostatistics and Biomarkers for the Reliability and Efficiency of Clinical Trials: A Conversation with Dr. Janet WittesThu, 13 Feb 2020
-
19 - An Inside Look at the Role of Data Monitoring Committees with Dr. Jonathan SeltzerThu, 13 Feb 2020
Mostrar más episodios
5
